Skip to main content
. 2016 Jan 3;7(8):8823–8838. doi: 10.18632/oncotarget.6815

Table 3. Univariate and multivariate Cox regression analyses of COL3A1 mRNA expression and clinical variables for overall and disease-free survival of CRC patientsa.

Survival Methods Variables βb SE (β)c Wald χ2 p Hazard ratio 95% CId
Low Upper
Overall-survival
Univariate Cox regression
Age 0.006 0.009 0.472 0.492 1.006 0.988 1.025
COL3A1 0.720 0.247 8.517 0.004 2.055 1.267 3.333
Grade 0.695 0.241 8.311 0.004 2.004 1.249 3.215
Recurrence 1.569 0.308 25.958 0.000 4.801 2.625 8.778
Sex 0.100 0.237 0.176 0.675 1.105 0.694 1.759
Stage 1.049 0.154 46.482 0.000 2.854 2.111 3.859
Multivariate Cox regression
Recurrence 1.407 0.315 20.010 0.000 4.084 2.205 7.565
Stage 0.441 0.207 4.531 0.033 1.554 1.036 2.333
Disease-Free survival
Univariate Cox regression
Age 0.003 0.008 0.116 0.733 1.003 0.986 1.020
COL3A1 0.500 0.226 4.903 0.027 1.648 1.059 2.565
Grade 0.692 0.230 9.062 0.003 1.997 1.273 3.133
Recurrence 2.272 0.293 60.110 0.000 9.703 5.463 17.235
Sex 0.051 0.222 0.052 0.819 1.052 0.681 1.626
Stage 0.985 0.141 48.820 0.000 2.677 2.031 3.528
Multivariate Cox regression
Recurrence 2.113 0.299 49.839 0.000 8.276 4.603 14.882
Stage 0.429 0.197 4.742 0.029 1.536 1.044 2.259
a

The analysis was performed using the Smith Colorectal dataset from the Oncomine cancer gene expression microarray DB (https://www.oncomine.org/resource/login.html).

b

β, regression coefficient.

c

SE, standard error.

d

CI, confidence interval.